$4.90 14.2%
GDRX Stock Price vs. AI Score
Data gathered: November 23

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - GoodRx (GDRX)

Analysis generated August 13, 2024. Powered by Chat GPT.

GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and a free-to-use website and mobile app which track prescription drug prices in the United States and provide drug coupons for discounts on medications. GoodRx’s approach is centered on improving access to healthcare through price transparency and consumer-focused digital solutions.

Read full AI stock Analysis

Stock Alerts - GoodRx (GDRX)

company logo GoodRx | November 22
Price is up by 5.1% in the last 24h.
company logo GoodRx | November 15
Price is down by -5% in the last 24h.
company logo GoodRx | November 11
App downloads are down by -33.3% in the last couple of days.
company logo GoodRx | November 7
Price is down by -6.7% in the last 24h.

About GoodRx

GoodRx Holdings, Inc. is an American healthcare company that operates a telemedicine platform and a free-to-use website and mobile app that track prescription drug prices in the United States and provide free drug coupons for discounts on medications. GoodRx checks more than 75,000 pharmacies in the United States.


GoodRx
Price $4.90
Target Price Sign up
Volume 2,980,000
Market Cap $1.64B
Year Range $4.15 - $9.05
Dividend Yield 0%
PE Ratio 276.37
Analyst Rating 46% buy
Industry Digital health

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '24193M145M48M4M-1.5M0.000
Q2 '24201M150M51M6.7M43M0.080
Q1 '24183M159M24M-1M31M0.080
Q4 '23182M177M5.1M-26M34M0.080
Q3 '23165M179M-13M-38M1.1M0.060

Insider Transactions View All

Nabiey Romin filed to sell 64,633 shares at $6.8.
August 14 '24
Wagner Scott filed to buy 182,900 shares at $5.8.
December 4 '23
Wagner Scott filed to buy 161,248 shares at $5.9.
November 30 '23

What is the Market Cap of GoodRx?

The Market Cap of GoodRx is $1.64B.

What is GoodRx's PE Ratio?

As of today, GoodRx's PE (Price to Earnings) ratio is 276.37.

What is the current stock price of GoodRx?

Currently, the price of one share of GoodRx stock is $4.90.

How can I analyze the GDRX stock price chart for investment decisions?

The GDRX stock price chart above provides a comprehensive visual representation of GoodRx's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling GoodRx shares. Our platform offers an up-to-date GDRX stock price chart, along with technical data analysis and alternative data insights.

Does GDRX offer dividends to its shareholders?

As of our latest update, GoodRx (GDRX) does not offer dividends to its shareholders. Investors interested in GoodRx should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of GoodRx?

Some of the similar stocks of GoodRx are Teladoc Health, Veeva Systems, Doximity, Lifestance Health, and Amwell.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.